News | February 29, 2024
Bajaj Healthcare enters into definitive CDMO Agreement for 15 APIs with UK/EU customers
BHL will undertake the development and supply of these molecules
BHL will undertake the development and supply of these molecules
This alliance brings together drug innovation capabilities of Glenmark and Ichnos to develop cutting-edge therapies for the treatment of hematological malignancies and solid tumors
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Total transaction value of the divestment is Rs. 3,660 million
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
Subscribe To Our Newsletter & Stay Updated
